Targeted next-generation sequencing-based multiple gene mutation profiling of patients with rectal adenocarcinoma receiving or not receiving neoadjuvant chemoradiotherapy

HIGHLIGHTS

• who: You-Kang Chang et al. from the Department of Radiation Oncology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taipei, Taiwan College of Medicine, Tzu Chi University, Hualien City, Taiwan have published the research work: Targeted Next-Generation Sequencing-Based Multiple Gene Mutation Profiling of Patients with Rectal Adenocarcinoma Receiving or Not Receiving Neoadjuvant Chemoradiotherapy, in the Journal: (JOURNAL) of 30/08/2022
• what: This study investigated whether oncogenic and tumor-suppressive mutations are involved in the differential outcomes of patients with carcinoma chemoradiotherapy (nCRT). The authors examined 55 samples from 29 patients . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.